EUVIMEDEUVIMED entdecken
Crossref

3D CEST imaging for differentiating malignant and benign prostatic areas: Diagnostic performance relative to DWI

Takahiro Ueda, Yoshiyuki Ozawa, Masahiko Nomura, Maiko Shinohara, Natsuka Yazawa, Kaori Yamamoto, Yuichiro Sano, Masato Ikedo, Masao Yui, Masanori Ozaki, Takeshi Yoshikawa, Daisuke Takenaka und 1 weitere

Magnetic Resonance Imaging · 2027-02 · 136 · 110830

DOI: 10.1016/j.mri.2026.110830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance Imaging, 2027-02. Verfasst von Takahiro Ueda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Canon Medical Systems Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: In contrast to diffusion-weighted imaging (DWI) and dynamic contrast-enhanced perfusion MRI, different information from chemical exchange saturation transfer (CEST) imaging has been suggested to have potential for diagnosis of prostate cancer. The purpose of this study was to compare the descriptor capability for differentiating malignant from benign prostatic areas among three-dimensional (3D) amide proton transfer weighted (APTw) imaging using a newly developed 3D CEST sequence, DWI, and the combined descriptor method. MATERIALS AND METHODS: Fifty-two prostate cancer patients underwent DWI and 3D APTw imaging, surgical treatments, and pathological examinations. Then, 154 areas were identified as malignant, and 154 out of 624 areas were computationally selected as benign. From 3D APTw imaging and DWI, magnetization transfer ratio asymmetry (MTRasym) in the 3.5 ppm map and apparent diffusion coefficient (ADC) within malignant and benign prostatic areas were determined by ROI measurements. Then, a logistic regression analysis was conducted to evaluate the descriptors. An ROC analysis and McNemar's test were conducted to compare the diagnostic performance of MTRasym, ADC, and the combined discriminator method. RESULTS: The logistic regression analysis identified MTRasym (unit odds ratio: 3.6, p < 0.0001) and ADC (unit odds ratio: 0.03, p < 0.0001) as significant descriptors. The area under the curve (AUC) of the combined descriptor method (AUC = 0.86) was significantly larger than that of MTRasym (AUC = 0.81, p = 0.001) and ADC (AUC = 0.76, p < 0.0001). CONCLUSION: 3D APTw imaging is considered at least as valuable as DWI to distinguish malignant from benign prostatic areas. Combined descriptors could improve diagnostic performance, relative to each sequence alone.

Schlagwörter

Stichwörter der Autor:innen

Chemical exchange saturation transferDiffusion weighted imagingMRIProstateProstate cancer

Autor:innen und Institutionen

  • Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; Joint Research Laboratory of Advanced Medical Imaging and Artificial Intelligence, Fujita Health University School…
  • Canon Medical Systems Corporation, Kawasaki, Kanagawa, Japan.
  • Canon Medical Systems Corporation, Kawasaki, Kanagawa, Japan; Canon Inc., Ota-Ku, Tokyo, Japan.
  • Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; Department of Radiology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.
  • Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; Department of Radiology, Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan.

Förderung

  • Canon Medical Systems Corporation

Zitieren

APA

Ueda, T., Ozawa, Y., Nomura, M., Shinohara, M., Yazawa, N., Yamamoto, K., Sano, Y., Ikedo, M., Yui, M., Ozaki, M., Yoshikawa, T., Takenaka, D., & Ohno, Y. (2027). 3D CEST imaging for differentiating malignant and benign prostatic areas: Diagnostic performance relative to DWI. Magnetic Resonance Imaging, 136, 110830. https://doi.org/10.1016/j.mri.2026.110830

Vancouver

Ueda T, Ozawa Y, Nomura M, Shinohara M, Yazawa N, Yamamoto K, et al. 3D CEST imaging for differentiating malignant and benign prostatic areas: Diagnostic performance relative to DWI. Magnetic Resonance Imaging. 2027;136:110830. doi:10.1016/j.mri.2026.110830

BibTeX
@article{Ueda2027,
  author = {Ueda, Takahiro and Ozawa, Yoshiyuki and Nomura, Masahiko and Shinohara, Maiko and Yazawa, Natsuka and Yamamoto, Kaori and Sano, Yuichiro and Ikedo, Masato and Yui, Masao and Ozaki, Masanori and Yoshikawa, Takeshi and Takenaka, Daisuke and Ohno, Yoshiharu},
  title = {3D CEST imaging for differentiating malignant and benign prostatic areas: Diagnostic performance relative to DWI},
  journal = {Magnetic Resonance Imaging},
  year = {2027},
  volume = {136},
  pages = {110830},
  doi = {10.1016/j.mri.2026.110830}
}
Kostenlos starten →